Literature DB >> 23077080

Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease susceptibility.

Tian-Biao Zhou1, Sheng-Sheng Yin, Yuan-Han Qin.   

Abstract

BACKGROUND AND
OBJECTIVE: The association between angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism and end-stage renal disease (ESRD) risk is still controversial. A meta-analysis was performed to evaluate the association between ACE I/D gene polymorphism and ESRD susceptibility.
METHOD: A predefined literature search and selection of eligible relevant studies were performed to collect data from electronic databases.
RESULTS: Thirty-four articles were identified for the analysis of an association between ACE I/D gene polymorphism and ESRD risk. Both D allele and DD genotype were associated with ESRD susceptibility in overall populations (D: OR = 1.20, 95% CI: 1.06-1.36, p = 0.003, DD: OR = 1.47, 95% CI: 1.20-1.78, p = 0.0001) and in East Asians (D: OR = 1.34, 95% CI: 1.06-1.69, p = 0.01, DD: OR = 2.01, 95% CI: 1.29-3.12, p = 0.002). Only the DD genotype had a positive association with ESRD susceptibility in Caucasians (OR = 1.20, 95% CI: 1.01-1.43, p = 0.03). The result from sensitivity analysis in overall populations or Caucasians was similar to those in non-sensitivity analysis, but not among East Asians.
CONCLUSIONS: The results of our study support the idea that D allele or DD genotype was associated with increased risk of ESRD susceptibility in the overall populations, and DD genotype was associated with ESRD susceptibility in Caucasians.

Entities:  

Keywords:  End-stage renal disease; angiotensin-converting enzyme; gene polymorphism; insertion/deletion; meta-analysis

Mesh:

Substances:

Year:  2012        PMID: 23077080     DOI: 10.1177/1470320312460898

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  6 in total

1.  ACE I/D and MMP-7 A-181G variants and the risk of end stage renal disease.

Authors:  Zohreh Rahimi; Hamed Abdi; Maryam Tanhapoor; Ziba Rahimi; Asad Vaisi-Raygani; Hamid Nomani
Journal:  Mol Biol Res Commun       Date:  2017-03

2.  Levels of vitamin D receptor and CYP24A1 in patients with end-stage renal disease.

Authors:  Jia-Jun Ye; Tian-Biao Zhou; Yun-Fang Zhang; Qi Wang; Yan-Yan Su; Jia-Min Tang; Hong-Yan Li
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

Review 3.  Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension--a meta-regression analysis of 98 observational studies.

Authors:  Chin Lin; Hsin-Yi Yang; Chia-Chao Wu; Herng-Sheng Lee; Yuh-Feng Lin; Kuo-Cheng Lu; Chi-Ming Chu; Fu-Huang Lin; Sen-Yeong Kao; Sui-Lung Su
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

4.  The role of genetic polymorphisms of the Renin-Angiotensin System in renal diseases: A meta-analysis.

Authors:  Georgia G Braliou; Athina-Maria G Grigoriadou; Panagiota I Kontou; Pantelis G Bagos
Journal:  Comput Struct Biotechnol J       Date:  2014-06-11       Impact factor: 7.271

5.  Polymorphism of angiotensin-converting enzyme (rs4340) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus.

Authors:  M Šeruga; J Makuc; M Završnik; I Cilenšek; R Ekart; D Petrovič
Journal:  Balkan J Med Genet       Date:  2017-03-04       Impact factor: 0.519

6.  Correlation of angiotensin I-converting enzyme gene insertion/deletion polymorphism with rheumatic heart disease: a meta-analysis.

Authors:  Yulong Tian; Zhongchun Ge; Yuliang Xing; Yan Sun; Jie Ying
Journal:  Biosci Rep       Date:  2016-11-22       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.